| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA716279 | F | Ability to reverse electroconvulsive shock induced amnesia in mice, after administering intraperitoneally at a dose of 1.25 mg/kg | Mus musculus | 26 | organism-based format | Scientific Literature | ||
| 2. | ALA716281 | F | Ability to reverse electroconvulsive shock (ECS) induced amnesia in mice, after administering intraperitoneally, at a dose of 10.0 mg/kg | Mus musculus | 5 | organism-based format | Scientific Literature | ||
| 3. | ALA716283 | F | Ability to reverse electroconvulsive shock induced amnesia in mice, after administering intraperitoneally at a dose of 2.5 mg/kg | Mus musculus | 27 | organism-based format | Scientific Literature | ||
| 4. | ALA716294 | F | Ability to reverse electroconvulsive shock induced amnesia in mice, after administering intraperitoneally at a dose of 5 mg/kg | Mus musculus | 31 | organism-based format | Scientific Literature | ||
| 5. | ALA727550 | F | Retention for passive avoidance learning in mice at dose 20 mg/kg | Mus musculus | 33 | organism-based format | Scientific Literature | ||
| 6. | ALA727553 | F | Retention for passive avoidance learning in mice at dose 5 mg/kg | Mus musculus | 12 | organism-based format | Scientific Literature | ||
| 7. | ALA726635 | F | Compound was tested for cognitive activity by measuring retention for passive avoidance learning in mice at dose 10 mg/kg | Mus musculus | 5 | organism-based format | Scientific Literature | ||
| 8. | ALA726639 | F | Compound was tested for lethality in mice at a dose 40 mg/kg intraperitoneally; L denotes lethal at this dose | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 9. | ALA817760 | B | Binding affinity against bovine trypsin | Bos taurus | 8 | single protein format | Scientific Literature | ||
| 10. | ALA821445 | B | Binding affinity against trypsin | 8 | single protein format | Scientific Literature | |||
| 11. | ALA1798575 | B | Irreversible inhibition of LSD1 | 6 | single protein format | Scientific Literature | |||
| 12. | ALA1909307 | A | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia | 888 | tissue-based format | Scientific Literature | |||
| 13. | ALA1909308 | A | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis | 888 | tissue-based format | Scientific Literature | |||
| 14. | ALA1909309 | A | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis | 888 | tissue-based format | Scientific Literature | |||
| 15. | ALA1909310 | A | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis | 888 | tissue-based format | Scientific Literature | |||
| 16. | ALA1909311 | A | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests | 888 | tissue-based format | Scientific Literature | |||
| 17. | ALA1909312 | A | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure | 888 | tissue-based format | Scientific Literature | |||
| 18. | ALA1909313 | A | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis | 888 | tissue-based format | Scientific Literature | |||
| 19. | ALA1909314 | A | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis | 888 | tissue-based format | Scientific Literature | |||
| 20. | ALA1909315 | A | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly | 888 | tissue-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!